Search for: "Boehringer-Ingelheim"
Results 1 - 20
of 441
Sorted by Relevance
|
Sort by Date
5 Apr 2020, 9:57 pm
Plaintiffs-Appellants Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Corp.; and Boehringer Ingelheim... [read post]
2 Aug 2023, 2:15 am
The Associate Director, Senior Counsel IP (Intellectual Property) supports Boehringer Ingelheim's Animal Health global biotech patent team by providing legal services to Clients in Boehringer Ingelheim’s Animal Health division, typically at the Executive Director level and below. [read post]
2 Aug 2023, 2:15 am
The Associate Director, Senior Counsel IP (Intellectual Property) supports Boehringer Ingelheim's Animal Health global biotech patent team by providing legal services to Clients in Boehringer Ingelheim’s Animal Health division, typically at the Executive Director level and below. [read post]
10 Aug 2016, 1:27 pm
The drug was produced by German manufacturer Boehringer Ingelheim Pharmaceuticals as a substitute to the drug warfarin. [read post]
22 Jun 2007, 2:09 am
Boehringer Ingelheim Ltd. and ors v. [read post]
3 Jul 2008, 7:54 pm
Boehringer Ingelheim v. [read post]
19 Apr 2013, 1:12 pm
Boehringer Ingelheim released the drug without an antidote to counteract internal bleeding. [read post]
20 Nov 2012, 8:32 am
This settlement was with pharmaceutical giant Boehrigner Ingelheim Pharmaceuticals Inc. [read post]
27 Jun 2007, 2:04 am
Comparative advertisements must not be misleading Boehringer Ingelheim Ltd and Others v Vetplus Ltd Court of Appeal “No interim injunction would issue to inhibit comparative advertising, whereby one trader promoted his goods over those of a rival, unless the claimant could show the advertising was misleading and he would probably win a permanent injunction at trial. [read post]
22 Mar 2018, 6:11 am
Reuters reports, “Boehringer Ingelheim will pay $13.5 million to” settle claims from all 50 state attorneys general “that the pharmaceutical company used deceptive and misleading marketing to promote” four drugs “for unapproved purposes. [read post]
10 Aug 2016, 1:27 pm
The drug was produced by German manufacturer Boehringer Ingelheim Pharmaceuticals as a substitute to the drug warfarin. [read post]
8 Nov 2007, 8:01 pm
., and Boehringer Ingelheim Corporation have announced their agreement to enter into a joint stipulation of dismissal without prejudice in their lawsuit over FLOMAX ® (tamsulosin hydrochloride, used to treat benign prostatic hyperplasia). [read post]
26 Oct 2012, 4:31 am
On October 25, the Department of Justice announced that Boehringer Ingelheim has agreed to pay $95 million to resolve a whistleblower’s allegations that the company promoted one of its drugs unlawfully, and thereby caused the submission of false claims. [read post]
2 Jun 2018, 5:55 am
Adrian ChewThe Court of Appeal dismissed Boehringer Ingelheim’s application for permission to appeal the first instance Patents Court decision that EP (UK) 1,379,220 lacked inventive step. [read post]
24 Feb 2017, 1:31 am
Adrian ChewBristowsThe Court of Appeal dismissed Boehringer Ingelheim’s application for permission to appeal the first instance Patents Court decision that EP (UK) 1,379,220 lacked inventive step. [read post]
27 Feb 2007, 9:32 pm
Boehringer Ingelheim is Astellas Pharma's U.S. marketing partner. [read post]
29 May 2014, 7:26 pm
You may have reason to pursue your products liability case against Boehringer Ingelheim and others. [read post]
8 May 2016, 9:59 pm
KG; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
15 May 2012, 9:39 am
The number of federal Pradaxa lawsuits filed against Boehringer Ingelheim Pharmaceuticals has risen to 18 after 8 more lawsuits were filed. [read post]
13 May 2010, 4:44 pm
The companies, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc. and Roxane Laboratories Inc., are all affiliates of German drug giant, Boehringer Ingelheim GmbH. [read post]
